https://medicine.ouhsc.edu/directory Parent Page: Directory id: 22535 Active Page: Detailsid:23325
Directory
Mati Ullah Dad Ullah, MD
Internal Medicine

Mati Ullah Dad Ullah, MD

Gastroenterology Fellow


800 Stanton L. Young Blvd.
ATT 7400
Oklahoma City, OK  73104


405-271-5585

MatiUllah-DadUllah@ou.edu

Academic Section(s):

Digestive Diseases and Nutrition

Education:

2014-2021  Medical School, King Edward Medical University, Pakistan
2021-2023  Department of Hepatology, Beth Israel Deaconess Medical
                    Center, Boston, MA

Residency:

2023-2026  Department of Medicine University of Oklahoma Health
                     Sciences Center, Oklahoma City, Oklahoma

Select Publications:

1. Khan IW, Dad Ullah MU, Choudhry M, Ali MJ, Ali MA, Lam SL, Shah PA, Kaur SP, Lau DT. Novel therapies of hepatitis B and D. Microorganisms. 2021 Dec 17;9(12):2607.

2. Dad Ullah MU, Shah SB, Rasikh R, Ullah A, Khalil Ur Rehman F, Ali IA. S3060 Trends and Indications for Intestinal (Small Bowel) Transplantation in the United States: A 12-Year Analysis (2012–2023) Using UNOS Data. American Journal of Gastroenterology. 2025 Oct;120(10S2):S658-9.

3. Ullah MU, Kelaiya AP, Rasikh R, Sakka M, Alkouri R, Ali MJ, Chen HW, Khan IW, Choudhry M, Ali MA, Deregnaucourt M. Application of LIVERFASt biomarkers to evaluate longitudinal hepatic fibrosis and inflammation after HCV cure. InThe Liver Meeting 2023 2023 Oct 1. AASLD.

4. Ullah MU, Ullah A, Tayyab H, Rasikh R. S2608 Declining Mortality in Alcohol-Associated Hepatitis: A National Analysis Using UNOS and CDC WONDER Databases (2012–2024). Official journal of the American College of Gastroenterology| ACG. 2025 Oct 1;120(10S2):S560.

5. Ullah MU, Rahman M, Sakka M, Alkouri R, Raza MA, Ali MJ, Reyes KC, Deregnaucourt M, Bonnefont-Rousselot D, Quiambao R, Munteanu M. APPLICATION OF LIVERFAST BIOMARKERS TO PREDICT STEATOSIS IN CHRONIC HEPATITIS B PATIENTS WITH METABOLIC SYNDROME. InThe Liver Meeting 2023 2023 Nov 11. AASLD.

6. Ali MJ, Ullah MD, Anderson M, McMahon B, Shah PA, Kaur SP, Cloherty GA, Lau D. HBsAg/anti-HBS immune complex persists up to 13 years after HBsAg lOSS. InHepatology 2022 Oct 1 (Vol. 76, pp. S36-S37). 111 RIVER ST, HOBOKEN 07030-5774, NJ USA: WILEY.

7. Aiman W, Iqbal R, Ali MA, Dad Ullah MU, Anwar A, Kloub MN, Shaaban HS. Impact of human immunodeficiency virus on hepatocellular carcinoma outcomes: A National Inpatient Sample.

8. Ullah A, Wazir H, Sultany A, Rehman KU, Sultani MI, Khan NA, Khan SA, Ullah MU, Gondal A. From Discovery to Cure—Where Are We Now? Mortality Trends in Chronic Hepatitis C: An Analysis of CDC WONDER Database (1999–2023). Viruses. 2026 May 20;18(5):576.

9. Hassam K, Raza MA, Ullah MU. The application of transient elastography for early diagnosis of pregnancy-related complications. American Journal of Obstetrics & Gynecology. 2024 Jan 1;230(1):104-5.